Berlin, Germany

Atanas Marinov Kamburov

This inventor holds 1 USPTO granted patent. Top assignee: Bayer Aktiengesellschaft. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Atanas Marinov Kamburov. Retrieved from https://idiyas.com/inventor/atanas-marinov-kamburov

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 14.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Atanas Marinov Kamburov: Patent Activity in Pharmaceutical Innovation.

Introduction

Atanas Marinov Kamburov is an inventor associated with Berlin, Germany, and Bayer Aktiengesellschaft. His listed patent concerns phosphorus derivatives developed as SOS1 inhibitors, a subject within pharmaceutical research.

Latest Patents

The provided information lists one patent for Kamburov: “Phosphorus derivatives as SOS1 inhibitors.” The invention covers phosphorus derivatives, methods for preparing them, useful intermediate compounds, pharmaceutical compositions, and combinations containing the compounds. It also describes their potential use in treating or preventing diseases, particularly hyperproliferative disorders associated with SOS1, either alone or alongside other active ingredients. The listed patent count is 1 patent.

Career Highlights

Kamburov’s listed patent connects his inventive work with the development of compounds and pharmaceutical approaches targeting SOS1. The available information associates him with Bayer Aktiengesellschaft and does not provide further details about his role or career history.

Collaborations

The provided information names Benjamin Bader and Jens Schröder as Kamburov’s coworkers. It does not specify their roles in the patent or the nature of their collaboration.

Conclusion

Atanas Marinov Kamburov’s listed patent reflects work on phosphorus-based SOS1 inhibitors and their potential pharmaceutical applications, associated with Bayer Aktiengesellschaft in Berlin.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…